Reversible, Orally Bioavailable Small-Molecule Inhibitors Occupy the Substrate Tunnel of the Thioesterase Domain of Fatty Acid Synthase
Joseph Fromm, Alexander Aleshin, Lester J. Lambert, Laurent J. S. De Backer, Santhi Reddy, Margrith E. Mattmann, Allison S. Limpert, Palak Gosalia, Carina D. Wimer, Fabiana Izidro Layng, Maria Celeridad, Robert Ardecky, Peter Teriete, David A. Scott, Michael P. Hedrick, , Nicholas D. P. Cosford
This paper reports the discovery of SBP-5917, a reversible FASN-TE inhibitor with submicromolar potency and cellular target engagement.
bioRxiv · Oct 7, 2026 · PreprintCell Biology